Trupanion, Inc. (NASDAQ:TRUP – Get Rating) gapped down before the market opened on Thursday after Canaccord Genuity Group lowered their price target on the stock from $100.00 to $90.00. The stock had previously closed at $68.00, but opened at $61.81. Trupanion shares last traded at $65.18, with a volume of 6,417 shares traded.
A number of other brokerages have also issued reports on TRUP. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $80.00 to $69.00 in a research note on Thursday. Northland Securities dropped their price target on shares of Trupanion from $80.00 to $70.00 in a research note on Thursday. Finally, Bank of America lowered their target price on shares of Trupanion from $118.00 to $110.00 and set a “buy” rating for the company in a research note on Wednesday, April 20th.
Insider Buying and Selling at Trupanion
In other Trupanion news, CEO Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $64.21, for a total transaction of $256,840.00. Following the completion of the sale, the chief executive officer now owns 857,109 shares in the company, valued at $55,034,968.89. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, Director Michael Doak sold 700 shares of the company’s stock in a transaction dated Tuesday, July 5th. The shares were sold at an average price of $60.00, for a total transaction of $42,000.00. Following the completion of the transaction, the director now owns 1,007 shares in the company, valued at $60,420. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the company’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $64.21, for a total transaction of $256,840.00. Following the transaction, the chief executive officer now owns 857,109 shares of the company’s stock, valued at approximately $55,034,968.89. The disclosure for this sale can be found here. Insiders sold a total of 21,700 shares of company stock worth $1,368,070 over the last 90 days. Insiders own 6.77% of the company’s stock.
Hedge Funds Weigh In On Trupanion
Trupanion Stock Up 4.7 %
The firm has a market cap of $2.77 billion, a price-to-earnings ratio of -76.50 and a beta of 2.02. The firm’s fifty day moving average is $62.81 and its two-hundred day moving average is $74.81. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.88 and a quick ratio of 1.88.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
- Get a free copy of the StockNews.com research report on Trupanion (TRUP)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.